← FDA ENFORCEMENT
F-1206-2024Class II

BF Suma Pharmaceuticals, Inc.

Recalling firm
BF Suma Pharmaceuticals, Inc.
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2024-05-08
Distribution
U.S. distribution to the following states: CA, TX. Foreign distribution to Canada and Guatemala.
Firm state
CA
Product quantity
59,873 boxes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Documentation & Change Control
Reason for recall

Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil

Product description

Longreen Corporation 4 in1 Reishi Coffee, 18.2 grams/sachet, 10 sachets/box

Code / lot info

Batch No. A34319, Best By Date: 12 2025; Batch No. A34419, Best By Date: 12 2025; Batch No. E34519, Best By Date: 04 2026; Batch No. E34619, Best By Date: 04 2026; Batch No. F34119, Best By Date: 05 2026; Batch No. F34219, Best By Date: 05 2026; Batch No. H34519, Best By Date: 07 2026; Batch No. H34619, Best By Date: 07 2026; Batch No. A43119, Best By Date: 12 2026; Batch No. A43219, Best By Date: 12 2026; Batch No. B41119, Best By Date: 01 2027; Batch No. B41219, Best By Date: 01 2027

Other recalls SPEQ maps to Documentation & Change Control
2026-07-22Class IIDaavlin Distributing Company2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class IIChocolate Bar Holdings LLC
See all Documentation & Change Control recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.